Kolexia
Thirot-Bidault Anne
Gastro-entérologie
Cabinet libéral
Antony, France
74 Activités
24 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénocarcinome Tumeurs du pancréas Tumeurs colorectales Métastase tumorale Tumeurs du foie Carcinomes Tumeurs du rectum Urgences Tumeurs du côlon

Industries

Amgen
5 collaboration(s)
Dernière en 2023
Servier
5 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2023
AstraZeneca
3 collaboration(s)
Dernière en 2023

Dernières activités

Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   17 janvier 2024
GEMPAX: A Phase III Randomized Study Evaluating Gemcitabine and Paclitaxel Versus Gemcitabine Alone After FOLFIRINOX Failure or Intolerance in Metastatic Pancreatic Ductal Adenocarcinoma
Essai Clinique (Unicancer)   07 novembre 2023
ADAGE: Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
POCHI: Pembrolizumab in Combination With Xelox Bevacizumab in Patients With Microsatellite Stable Mestatic Colorectal Cancer and a High Immune Infiltrate : a Proof of Concept Study
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
OSCAR: Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
Essai Clinique (Fédération Francophone de Cancérologie Digestive)   16 août 2023
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.
European journal of cancer (Oxford, England : 1990)   07 juin 2023
Multicentre, interventional, single-arm study protocol of telemonitored circadian rhythms and patient-reported outcomes for improving mFOLFIRINOX safety in patients with pancreatic cancer (MultiDom, NCT04263948).
BMJ open   07 juin 2023
DONEPEZOX: Evaluation of the Efficacy of Donepezil in the Treatment of Oxaliplatin-induced Peripheral Neuropathy: Proof of Concept Study
Essai Clinique (CHU Clermont-Ferrand)   25 avril 2023
MULTIDOM: Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Domomedecine Plateform
Essai Clinique (Ramsay Générale de Santé)   20 avril 2023
A multicenter telemonitoring-telecare study with automatic assessment of physiological parameters and patient-reported outcomes in remote pancreatic cancer patients on mFOLFIRINOX: Interim technology report.
2022 ASCO Annual Meeting I   02 juin 2022